Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

CUSIP: 00461U105

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
+4,048,205
Put/Call ratio
110%
SEC-reported price per share
$13.96
Number of holders
112
Value change
+$55,162,166
Number of buys
58
Open additional details 1 more signal available
Number of sells
34
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
138,752,791

Security key

00461U105

Report period

Q2 2022

Institutions

112

Top holders

10

Ownership snapshot

Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F Lead comparable stake: 4.1% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 4.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 4.1%
Venrock Adviser, LLC 3.3%
BlackRock Finance, Inc. 2.9%
BVF INC/IL 2.9%
Rock Springs Capital Management LP 2.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
4.1%
$98,789,000
5,730,253 shares
31 Mar 2022
Venrock Adviser, LLC
13F
Company
13F
3.3%
$78,683,000
4,563,962 shares
31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
2.9%
$68,738,000
3,987,107 shares
31 Mar 2022
BVF INC/IL
13F
Company
13F
2.9%
$68,556,000
3,976,543 shares
31 Mar 2022
Rock Springs Capital Management LP
13F
Company
13F
2.8%
$66,633,000
3,865,034 shares
31 Mar 2022
Foresite Capital Management IV, LLC
13F
Company
13F
2.1%
$49,979,000
2,899,034 shares
31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
112
Shares
63,269,555
Rows available
112
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
107
Q2 2022 holders
112
Holder diff
5
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .